全部 标题 作者
关键词 摘要

OALib Journal期刊
ISSN: 2333-9721
费用:99美元

查看量下载量

相关文章

更多...

Progressive Multifocal Leukoencephalopathy in a 62-Year-Old Immunocompetent Woman

DOI: 10.1155/2014/549271

Full-Text   Cite this paper   Add to My Lib

Abstract:

Progressive multifocal encephalopathy (PML) is a rare demyelinating disease that typically presents in immunodeficient patients. We report a case of a previously healthy 62-Year-Old woman who suffered from an unsteady gait, throbbing headaches, and progressive left-sided weakness and numbness. Stroke was initially suspected based on imaging and symptoms. A series of follow-up magnetic resonance images of the brain showed a right parietal lesion growing in size as the patient became unable to walk and experienced increasing lethargy and confusion. A biopsy of the lesion was positive for the John Cunningham virus (JCV). A diagnosis of PML was made and she was started on mefloquine. No improvement was seen on this treatment and her condition worsened. Although PML remains uncommon in immunocompetent individuals, it cannot be ruled out based on their immune status. Although the exact cause remains uncertain, underlying or transient states of immunosuppression may be responsible for reactivation of the JCV in these patients. 1. Introduction Progressive multifocal leukoencephalopathy (PML) is a demyelinating disease of the central nervous system that typically occurs in immunosuppressed individuals. It is caused by reactivation of the John Cunningham virus (JCV) and infection of glial cells. It is often fatal, with a median life expectancy of less than six months following onset of symptoms [1]. Reports of PML afflicting immunocompetent patients are extremely rare but not unknown. We describe a patient with no previous medical issues and an intact immune system who presented with PML. 2. Case Presentation A 62-year-old female with no past medical history presented to the emergency department after a one-month history of progressive left-sided numbness, weakness, and unsteady gait. She had also experienced multiple falls and bladder incontinence over the past two weeks. She complained of frequent throbbing headaches in the occipital area that were not relieved by analgesics. The patient denied fever, chills, confusion, visual changes, or seizures. She had not sought any medical attention prior to this point and was not on any medication. She was of Portuguese origin and was married with two adult children. She had previously worked as a salesperson. She had never smoked and had no history of illicit drug or alcohol use. She denied recent travel, sick contacts, or exposure to wildlife. Family history was unremarkable. On examination, she was alert and oriented to person, time, and place. Some slight left-sided tongue deviation as well as decreased motor

References

[1]  J. R. Berger, L. Pall, D. Lanska, and M. Whiteman, “Progressive multifocal leukoencephalopathy in patients with HIV infection,” Journal of NeuroVirology, vol. 4, no. 1, pp. 59–68, 1998.
[2]  C. Wüthrich, X. Dang, S. Westmoreland et al., “Fulminant JC virus encephalopathy with productive infection of cortical pyramidal neurons,” Annals of Neurology, vol. 65, no. 6, pp. 742–748, 2009.
[3]  B. J. Brew, N. W. S. Davies, P. Cinque, D. B. Clifford, and A. Nath, “Progressive multifocal leukoencephalopathy and other forms of JC virus disease,” Nature Reviews Neurology, vol. 6, no. 12, pp. 667–679, 2010.
[4]  G. Perez-Liz, L. del Valle, A. Gentilella, S. Croul, and K. Khalili, “Detection of JC virus DNA fragments but not proteins in normal brain tissue,” Annals of Neurology, vol. 64, no. 4, pp. 379–387, 2008.
[5]  I. J. Koralnik, D. Schellingerhout, and M. P. Frosch, “Case 14-2004: a 66-year-old man with progressive neurologic deficits,” The New England Journal of Medicine, vol. 350, no. 18, pp. 1882–1893, 2004.
[6]  T. A. Yousry, E. O. Major, C. Ryschkewitsch et al., “Evaluation of patients treated with natalizumab for progressive multifocal leukoencephalopathy,” The New England Journal of Medicine, vol. 354, no. 9, pp. 924–933, 2006.
[7]  D. B. Clifford, A. DeLuca, D. M. Simpson, G. Arendt, G. Giovannoni, and A. Nath, “Natalizumab-associated progressive multifocal leukoencephalopathy in patients with multiple sclerosis: lessons from 28 cases,” The Lancet Neurology, vol. 9, no. 4, pp. 438–446, 2010.
[8]  K. R. Carson, A. M. Evens, E. A. Richey et al., “Progressive multifocal leukoencephalopathy after rituximab therapy in HIV-negative patients: a report of 57 cases from the Research on Adverse Drug Events and Reports project,” Blood, vol. 113, no. 20, pp. 4834–4840, 2009.
[9]  S. Gheuens, G. Pierone, P. Peeters, and I. J. Koralnik, “Progressive multifocal leukoencephalopathy in individuals with minimal or occult immunosuppression,” Journal of Neurology, Neurosurgery and Psychiatry, vol. 81, no. 3, pp. 247–254, 2010.
[10]  I. L. Tan, I. J. Koralnik, J. A. Rumbaugh, P. C. Burger, A. King-Rennie, and J. C. McArthur, “Progressive multifocal leukoencephalopathy in a patient without immunodeficiency,” Neurology, vol. 77, no. 3, pp. 297–299, 2011.
[11]  R. Friedman, “News from the AAN annual meeting: malaria drug fails to fulfill promise in PML,” Neurology Today, vol. 11, no. 8, p. 8, 2011.
[12]  M. Brickelmaier, A. Lugovskoy, R. Kartikeyan et al., “Identification and characterization of mefloquine efficacy against JC virus in vitro,” Antimicrobial Agents and Chemotherapy, vol. 53, no. 5, pp. 1840–1849, 2009.
[13]  H. Naess, S. Glad, A. Storstein et al., “Progressive multifocal leucoencephalopathy in an immunocompetent patient with favourable outcome. A case report,” BMC Neurology, vol. 10, article 32, 2010.
[14]  S. Gheuens, E. Bord, S. Kesari et al., “Role of CD4+ and CD8+ T-cell responses against JC virus in the outcome of patients with progressive multifocal leukoencephalopathy (PML) and PML with immune reconstitution inflammatory syndrome,” Journal of Virology, vol. 85, no. 14, pp. 7256–7263, 2011.
[15]  D. B. Clifford, C. Yiannoutsos, M. Glicksman et al., “Haart improves prognosis in HIV-associated progressive multifocal leukoencephalopathy,” Neurology, vol. 52, no. 3, pp. 623–625, 1999.
[16]  D. I. Zonios, J. Falloon, J. E. Bennett et al., “Idiopathic CD4+ lymphocytopenia: natural history and prognostic factors,” Blood, vol. 112, no. 2, pp. 287–294, 2008.

Full-Text

comments powered by Disqus

Contact Us

service@oalib.com

QQ:3279437679

WhatsApp +8615387084133